Earnings
Mesoblast Limited reported operational highlights and financial results for the first quarter ended September 30, 2019.
Medexus Pharmaceuticals Inc. announced that it plans to host a conference call at 8:00 AM Eastern Time on Monday, December 2, 2019 to discuss the Company’s financial results for the second quarter ended September 30, 2019, as well as the Company’s corporate progress and other developments.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, reported financial and operating results for the fourth quarter and fiscal year ended August 31, 2019 and provided a business update.
PCI Biotech, a cancer focused biopharmaceutical company announces its third quarter 2019 result.
The press release will be available on the Company’s website (www.kewaunee.com) after it has been issued.
The Board of Directors resolved on a rights issue of 75 MSEK, guaranteed to 80 percent, where the subscription period is ongoing
Vivoryon Therapeutics AG, will publish its third quarter financial results and a business update for the period ended September 30, 2019 on Thursday, November 28, 2019, in the form of an interim management report.
Epigenomics AG announced its financial results for the first nine months of 2019.
ADL Bionatur Solutions, a company specialized in the research and development of health, cosmetic and beauty products, services and industrial fermentation production, reported financial results for the third quarter and first nine months of 2019.
Generates over USD 1 million in sales through new POCare platform
PRESS RELEASES